Law firm marketing Mass tort
Guide · Mass tort economics
What a mass tortclaimant actuallycosts you
Mass tort is not personal injury with a bigger budget. It is campaign work rather than evergreen work, and the money disappears in ways an injury firm does not expect.
The reframe that matters. Three completely different things get called "a lead", and firms compare their prices as though they were the same number. They are not close.
Single-event injury economics are a different problem and they are on the personal injury lead costs guide. What follows is about campaigns with a filing window, a maturity curve and a documented fraud problem.
The core reframe
Three things called"a lead"
Raw
A form fill. Somebody typed something. The phone number may be wrong, the exposure is unconfirmed and there is no diagnosis on file.
You still have to: reach them, verify exposure, confirm a qualifying diagnosis, obtain records, and sign them.
Qualified
Contacted by a human. Exposure verified against the criteria, a qualifying diagnosis confirmed. No retainer yet.
You still have to: sign them, and hold them through a process that may run for years.
Signed retainer
Vetted, documented and under retainer. Ready to file, with the supporting material behind it.
You still have to: hold the file and do the work. But you have a claimant rather than a phone number.
A cheap raw lead against an expensive signed retainer is not a comparison, and the gap between them is not a markup. It is all the work that has to happen either way, priced by whoever does it. If you buy raw, you are buying that work back as staff time, records costs and the cases that fall out at verification.
Prices for each tier circulate widely in this industry and we are not going to print them as market rates, because the figures in general circulation trace back to a small number of commercial trackers whose other numbers do not survive checking. Ask three vendors for tier-specific pricing on the same tort in the same week and you will have better data than any published range.
The variable that beats execution
When you enterdecides more thanhow well you advertise
Every tort runs a curve. Early, the filing window is open and the pool of potential claimants is largely untouched, but nobody has proven the litigation works and lead prices reflect scarcity rather than certainty. Late, the tort is on television, the vendors are established, prices look reasonable, and the qualified universe has been called repeatedly by everyone who got there first.
That second state is the trap, because it feels like the safe option. The advertising is proven, the case criteria are settled and the price per lead has come down. What has also happened is that the people who qualify have already signed with somebody, and what remains is the population that has been rejected several times and has learned which answers get them through a screening call.
The workable posture is to look for emerging torts with a meaningful runway ahead of the filing window rather than buying into whatever is currently being advertised heavily. That requires a view on litigation you do not yet have proof of, which is exactly why it pays and exactly why most firms do not do it.
The operational half of timing
The speed comes fromwhat you built beforethe announcement
A tort breaks on a Tuesday. A statute passes, an MDL is consolidated, a bellwether lands, a regulator acts. The untouched pool starts being worked that week, and the firms who reach it are the ones who were already ready.
Which creates the obvious tension with everything else on this page. We have just told you to enter early and to run serious diligence on anybody selling you a claimant. Under a two-week clock those two instructions pull in opposite directions, and the firms that resolve it by skipping the diligence are the ones who end up in the fraud statistics.
Build it now
Before any tort is on the table- Vendor agreements already negotiated. Consent documentation, scrubbing evidence, audit rights and what happens to a failed lead, all agreed while nobody is in a hurry. You will not win those clauses in 48 hours
- An intake template. The qualification logic changes per tort; the routing, recording, escalation and after-hours cover do not
- A compliance-reviewed page structure, so only the tort-specific claims need fresh review rather than the whole asset
- Counsel on notice with an agreed turnaround for that review
- A records retrieval route already engaged and tested
- Entry criteria written down while you are calm: what would make this worth doing, and what would make you pass
- Capital identified. Nobody arranges working capital in a week
Never compress these
However short the window feels- Diligence on a vendor you have not used before. A new supplier in a hurry is the exact combination that produced the fabricated-claimant problem
- Compliance review of tort-specific claims. New disease language, new eligibility statements and new urgency copy all need looking at
- Your qualification criteria. Loosening them to hit a volume target is how a campaign quietly becomes an inventory problem
- The decision itself. "The vendor needs an answer by Friday" is a sales technique, not a filing deadline
There is also a sequencing move that resolves most of the pressure, and remarkably few firms use it. Split the launch in two. Your own channels carry no third-party consent risk, because you are the one capturing the inquiry: a landing page and a search campaign on your own account can be live within days of an announcement, subject only to your own compliance review. Purchased leads wait until the vendor file is complete.
That gets you into the market during the window that matters while the part that creates exposure proceeds at its own pace. It also has a useful side effect. A fortnight of your own traffic tells you what qualification actually looks like on this tort, which is a far better basis for judging a vendor's conversion claims than the vendor's own historical figures.
Set the entry criteria against the arithmetic rather than the excitement. What a defensible signed claimant would have to cost, given the fee available on that specific tort, is a question you can answer in an afternoon on the cost per signed case guide and should answer before the first invoice rather than after the third.
The California category the national playbook misses
Wildfire and otherevent-driven claims
Most mass tort advice is written about pharmaceutical and product litigation. The largest mass claim events in this state are not that, and almost everything about how they work is different.
California wildfire litigation against an investor-owned utility is a mass claim event with a local footprint, an institutional defendant and a legal theory that has no equivalent in product litigation. Edison International's own annual report describes the position plainly: California courts have found investor-owned utilities strictly liable for property damage, regardless of fault, by applying inverse condemnation where the utility's facilities were a substantial cause of a fire. The stated rationale is that damage from a public improvement can be spread across the community that benefited from it, through electric rates.
That does not make the outcome automatic, and it is worth being precise. The application of the doctrine is actively contested in current wildfire litigation, and recovery runs through a regulated structure rather than an ordinary defendant's balance sheet: the fund established under AB 1054 in 2019, after the 2017 and 2018 fires and the PG&E bankruptcy, sits behind eligible claims alongside a codified prudency standard.
On speed, the January 2025 Los Angeles fires are the sharpest illustration available of the previous section. The Eaton Fire ignited on 7 January. The first civil complaints on behalf of homeowners, renters, evacuees and business owners were filed on 13 January. Six days. No firm assembled a vendor stack, a compliance review and an intake process in six days; the ones who filed had those things already.
These claimants are in acute crisis, and the rules know it
California has no special waiting period for soliciting disaster victims. What it has is Rule 7.3, and the ordinary rule bites unusually hard in this situation.
Rule 7.3(b) prohibits solicitation that involves intrusion, coercion, duress or harassment. A person whose house burned down last week is the case that provision was written for, and the line between outreach and intrusion is shorter than it is anywhere else in this guide. Rule 7.3(c) applies equally directly: a mailer sent to addresses inside a burn perimeter is a targeted written communication to people known to need legal services in a particular matter, which brings the "Advertisement" labeling requirement with it.
The safe ground is the same as everywhere: communications directed to the general public are not solicitation, and that expressly includes a website and communications generated in response to searches. People in this position search, and they search early. Publishing clearly and being findable is both the compliant route and, in a market where every firm has the same map, usually the effective one. The California advertising rules guide sets out the whole framework.
Wildfire is the largest example of the category rather than the whole of it. The same shape recurs whenever a discrete event causes widespread local harm and there is an institutional defendant behind it: utility gas releases, refinery and industrial incidents, water contamination, dam and infrastructure failures, and the debris flows that follow a burn scar into the next rainy season. In each, the universe is geographic and knowable, the claimants are local and distressed, and readiness beats budget.
If your firm is in Southern California, this category deserves a plan before it deserves a campaign. The two questions worth settling in advance are whether you would take this work at all, and what a defensible signed claimant would need to cost given the recovery structure involved. Neither is answerable in the week after a fire.
The cautionary case
Camp Lejeune,honestly
Nobody agrees what happened, and that is the first lesson
Camp Lejeune is cited constantly as the example of undisciplined mass tort entry. The figures used to tell that story do not survive checking, and we think the disagreement is more instructive than any single number would be.
- Industry advertising spend
- $130M to $250M
- Administrative claims filed
- 152,000 to 550,000
- Share that qualified
- no reliable figure
The spend range comes from two industry trackers who differ by roughly a factor of two; Reuters, citing the research firm X Ante, reported around $130 million, while a mass tort advertising intelligence service puts it at $250 million. The claim counts vary by source and by whether duplicates are stripped: CNN, quoting a named US Navy spokesperson, reported more than 385,000 claims as of early August 2024, and other counts run from roughly 152,000 up to 550,000 gross.
If the industry cannot agree within a factor of two what it spent on the largest campaign in its history, no firm should be building a budget on those numbers. Widely repeated qualification percentages trace to a single commercial source and we could not corroborate them.
The number that actually governed the economics
The administrative claim deadline was 10 August 2024, and the window is closed. That much is not in dispute.
More consequentially, the Department of Justice states the position of the United States that the Federal Tort Claims Act fee cap applies to claims under the Act, so contingency fee arrangements cannot exceed 20% for administrative claims or 25% for suits filed in court, citing 28 U.S.C. § 2678.
A firm that modeled acquisition against a conventional contingency rate was working from a fee a third or more larger than the one available. That is not a marketing error and no amount of campaign skill corrects it. It is the reason to read the statute governing a tort before buying a single lead for it.
Documented, not theoretical
The fraud problem,and whose problem it is
In October 2023, a large plaintiff firm told an industry conference that it had spent months auditing claimant referrals received from other lawyers and concluded that hundreds were bogus, frequently supported by doctored medical records and invented diagnoses. Its audit identified 105 call centers in India and other Asian countries tied to fabricated leads in mass tort cases including Camp Lejeune. Claimants had been recruited who visited the base rather than lived there, or who were too young at the time of exposure to recall anything. The firm said it had passed the material to the Department of Justice and the FBI, which declined to confirm or deny an investigation.
Reported by Stars and Stripes and Insurance Journal, October 2023. This is one firm's internal audit described publicly by that firm, not a government finding, and it should be read as the account of an interested party. It is nonetheless the most detailed public description of the mechanism that exists.
That is the part firms get wrong. Diligence on a lead vendor is not procurement hygiene, it is your own exposure. Law firms have already been accused of federal telemarketing violations in connection with Camp Lejeune advertising, and a contract that pushes responsibility onto a vendor does not move the professional obligation off the firm whose name appears on the claim.
- Documented prior express written consent, per lead Not a blanket assurance in the master agreement. Per claimant, retrievable on demand, for every lead you are invoiced for.
- A full audit trail for that consent The source page the claimant saw, the timestamp, and the IP address where consent was captured. If a vendor cannot produce this per lead, you are buying an assertion.
- Do-not-call and state list scrubbing, evidenced Federal and state lists, with records of when each scrub ran. Ask what happens to a lead that fails a scrub, and whether you are still billed for it.
- Independent medical verification Records obtained through a route you can audit, not a summary typed by whoever made the call. Doctored records are the specific failure documented above.
- Where the call originated, in writing Which centers, in which countries, under whose supervision. Vendors who subcontract without telling you are the mechanism by which this happened at scale.
- A hard look at affiliate traffic Pre-checked consent boxes and sweepstakes incentives produce paperwork that looks documented and is not. These are the leads that pass a contract review and fail a regulator's.
Run every vendor contract past your own compliance counsel before signing. We are a marketing agency and this list is a commercial starting point, not a legal review of your agreement.
Two things that decide the portfolio
Fewer, stronger,answered faster
A firm signing five hundred marginal claimants can recover less than a firm signing a hundred and fifty strong ones. Weak files do not simply fail on their own; they sit in the inventory, and an inventory with a high proportion of unsupportable claims drags the value of the supportable ones with it when the numbers are being discussed. Count is the metric vendors sell on. It is not the metric that pays.
The other decider is response time, and at mass tort prices it is the most expensive intake problem anywhere in this build. A claimant who fills in a form is usually filling in several, and at a thousand dollars or more per lead a callback that arrives the following day is an extraordinarily costly habit. Figures circulate for exactly how much is lost to a slow callback and we have not been able to source them, but the direction is well established in the response-time research on the intake conversion guide, and the missed call calculator will size it at your own lead cost rather than a generic one.
Blend it all into a single figure at the end: what a signed, documented, defensible claimant costs you across the whole campaign, including the leads that failed verification and the staff time spent failing them. That number, not the invoice price of a lead, is what tells you whether the tort was worth entering. The method is on the cost per signed case guide.
Thinking about entering a tort?
Thirty minutes. We look at the tier you are actually being quoted, what your blended cost per signed claimant would need to be, and whether the timing works.
Nothing on this page is legal advice, and we are a marketing agency rather than your compliance counsel. Vendor agreements, consent practices and claim criteria should be reviewed by a lawyer who advises your firm. Third-party figures are attributed to their sources and, where those sources conflict, the page gives the range rather than choosing one.
Questions firms ask us about this
Straightanswers
Should we buy raw leads or signed retainers?
It depends entirely on whether you have the intake capacity to do the work that a raw lead still requires. Buying raw and running verification yourself can be cheaper per signed claimant if you are genuinely equipped for it, and considerably more expensive if you are not, because the work happens either way.
The mistake is buying raw because the number looked better, then discovering that verification, records retrieval and the fallout rate consume more than the price difference. Model both to a blended cost per signed claimant before choosing.
How do we know a vendor's leads are legitimate?
Ask for the artifacts rather than the assurances. Per-lead consent documentation with the source page, timestamp and IP; evidence of do-not-call and state list scrubbing; a written statement of which call centers handled the traffic and where they are; and a medical verification route you can audit independently.
A vendor who can produce those quickly is used to being asked. A vendor who explains why it is unnecessary has told you something useful. Have your compliance counsel review the agreement before you sign it, not after the first invoice.
Is it too late to enter a tort that is already advertising heavily?
Usually, for the economics you are hoping for. Heavy advertising means the qualified pool has been worked repeatedly, and what is left tends to include people who have been screened out elsewhere and have learned which answers get them through.
That is a quality problem before it is a cost problem. If you enter late, tighten qualification rather than loosening it to hit a volume target, and expect a lower conversion from lead to defensible claimant than the vendor's historical figures suggest.
Why won't you give us benchmark lead prices?
Because the figures in general circulation come from a small number of commercial trackers, and when we checked their other numbers against independent reporting they did not hold up. Two trackers differ by roughly a factor of two on what the industry spent on Camp Lejeune, and published claim counts vary by hundreds of thousands depending on the source.
Quoting a price range built on that would be doing the thing this page warns against. Three tier-specific quotes on the same tort in the same week will tell you more about your actual market than any published benchmark, and they cost nothing but an email.
Next step
Thirty minutes.
No pitch deck.
We'll work through the tier you are being quoted, the blended cost per signed claimant, and whether the timing works. More on the method at law firm marketing.
★★★★★ 4.9 across 312 reviews No obligation · Usually booked 1-2 days out